Delgado-LóPez P D, Corrales-GarcíA E M, Martino J, et al. Diffuse low-grade glioma: a review on the new molecular classification, natural history and current management strategies [J]. Clin Transl Oncol,2017, 19(8): 1-14.
Park J E, Kim H S, Park K J, et al. Pre- and posttreatment glioma: comparison of amide proton transfer imaging with MR spectroscopy for biomarkers of tumor proliferation [J]. Radiology, 2015, 278(2): 142979.
[4]
Jiang T, Mao Y, Ma W, et al. CGCG clinical practice guidelines for the management of adult diffuse gliomas [J]. Cancer Lett, 2016, 375(2): 263-273.
[5]
Zhu H F, Zhang Y X, Zhao X D. Animal models of human glioma: the progress of application and investigation[J]. Dongwuxue Yanjiu, 2012, 33(3): 337-342.
[6]
Ismail F S, Moinfar Z, Prochnow N, et al. Dexamethasone and levetiracetam reduce hetero-cellular gap-junctional coupling between F98 glioma cells and glial cells in vitro [J]. J Neurooncol, 2017, 131(3): 469-476.
[7]
Han X, Li H, Zhang Y, et al. Brain lipid-binding protein promotes proliferation and modulates cell cycle in C6 rat glioma cells [J]. Int J Oncol,2017,51(5):1439-1448.
[8]
Connolly N P, Stokum J A, Schneider C S, et al. Genetically engineered rat gliomas: PDGF-driven tumor initiation and progression in tv-a transgenic rats recreate key features of human brain cancer [J]. PLoS One, 2017, 12(3): e0174557.
[9]
Tian J, Ling Q I, Pengyan J I, et al. Induction effect of NPPB on apoptosis of human glioma SHG-44 cells and its mechanism [J]. J Jilin Uni, 2016, 42(4): 637-641.
[10]
Shchelkunov S N, Razumov I A, Kolosova I V, et al. Virotherapy of the malignant U87 human glioblastoma in the orthotopic xenotransplantation mouse SCID model [J]. Dokl Biochem Biophys, 2018, 478(1): 30-33.
[11]
He Y N, Zhang S C, Zhang H M. Pathologic changes of spontaneous tumors in Sprague-Dawley and Wistar rats[J]. Zhonghua Bing Li Xue Za Zhi, 2017, 46(4): 249-254.
[12]
Biasibetti E, Valazza A, Capucchio M T, et al. Comparison of allogeneic and syngeneic rat glioma models by using MRI and histopathologic evaluation [J]. Comp Med, 2017, 67(2): 147-156.
[13]
Coutinho D P, Smith N, Atolagbe O, et al. OKN-007 decreases free radical levels in a preclinical F98 rat glioma model [J]. Free Radic Biol Med, 2015, 87:157-168.
[14]
Desmarais G, Charest G, Therriault H, et al. Infiltration of F98 glioma cells in Fischer rat brain is temporary stimulated by radiation [J]. Int J Radiat Biol, 2016, 92(8): 444-450.
Nagaraja T N, Elmghirbi R, Brown S L, et al. Reproducibility and relative stability in magnetic resonance imaging indices of tumor vascular physiology over a period of 24h in a rat 9L gliosarcoma model [J]. Magn Reson Imaging, 2017, 44:131-139.
Pei J, Park I H, Ryu H H, et al. Sublethal dose of irradiation enhances invasion of malignant glioma cells through p53-MMP 2 pathway in U87MG mouse brain tumor model [J]. Radiat Oncol, 2015, 10(1): 1-11.
Liu W J, Yin Y B, Sun J Y, et al. Natural borneol is a novel chemosensitizer that enhances temozolomide-induced anticancer efficiency against human glioma by triggering mitochondrial dysfunction and reactive oxide species-mediated oxidative damage [J]. Onco Targets Ther, 2018, 11:5429-5439.
[22]
Shen Z G, Liu X Z, Chen C X, et al. Knockdown of E2F3 inhibits proliferation, migration, and invasion, and Increases apoptosis in glioma cells [J]. Oncol Res, 2017, 25(9): 1555-1566.
[23]
Leten C, Trekker J, Struys T, et al. Monitoring the bystander killing effect of human multipotent stem cells for treatment of malignant brain tumors [J]. Stem Cells Int, 2016, 2016(10): 4095072.
[24]
Parrish K E, Pokorny J, Mittapalli R K, et al. Efflux transporters at the blood-brain barrier limit delivery and efficacy of cyclin-dependent kinase 4/6 inhibitor palbociclib (PD-0332991) in an orthotopic brain tumor model [J]. J Pharmacol Exp Ther, 2015, 355(2): 264-271.
[25]
Tsou Y H, Zhang X Q, Zhu H, et al. Drug delivery to the brain across the blood-brain barrier using nanomaterials [J]. Small, 2017, 13(43): 1701921.
2019, Vol. 30 
